Back
Beazer Homes USA 10K Form
Sell
41
BZH
Beazer Homes USA
Last Price:
$28.09
Seasonality Move:
-2.93%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-01 | 10Q | BZH/Beazer Homes USA Quarterly |
2024-02-01 | 10Q | BZH/Beazer Homes USA Quarterly |
2023-11-16 | 10K | BZH/Beazer Homes USA Annual |
2023-07-27 | 10Q | BZH/Beazer Homes USA Quarterly |
2023-04-27 | 10Q | BZH/Beazer Homes USA Quarterly |
2023-02-02 | 10Q | BZH/Beazer Homes USA Quarterly |
Receive BZH News And Ratings
See the #1 stock for the next 7 days that we like better than BZH
BZH Financial Statistics
Sales & Book Value
Annual Sales: | $2.3B |
---|---|
Cash Flow: | $179.8M |
Price / Cash Flow: | 0 |
Annual Sales: | $39.68 |
Price / Book: | 0.71 |
Profitability
EPS (TTM): | 4.53000 |
---|---|
Net Income (TTM): | $140.2M |
Gross Margin: | $424.3M |
Return on Equity: | 12.09% |
Return on Assets: | 5.61% |
Beazer Homes USA Earnings Forecast
Key Beazer Homes USA Financial Ratios
-
The Gross Profit Margin over the past 32 years for BZH is 18.21%.
-
The Selling, General & Administrative Expenses for BZH have been equal to 8.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of BZH is 6.02% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 20 years.
Beazer Homes USA Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Household Durables |
Sector: | Consumer Discretionary |
Current Symbol: | BZH |
CUSIP: | 07556Q |
Website: | beazer.com |
Debt
Debt-to-Equity Ratio: | 0.83 |
---|---|
Current Ratio: | 10.17 |
Quick Ratio: | 1.17 |
Price-to-Earnings
Trailing P/E Ratio: | 6.25 |
---|---|
Forward P/E Ratio: | 4.83 |
BZH Technical Analysis vs Fundamental Analysis
Sell
41
Beazer Homes USA (BZH)
is a Sell
Is Beazer Homes USA a Buy or a Sell?
-
Beazer Homes USA stock is rated a SellThe current Beazer Homes USA [BZH] share price is $28.32. The Score for BZH is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.